Grace Introduces Disposable Purification Solution to Lower Cost and Accelerate Drug Development For Biotech

COLUMBIA, Md. - W. R. Grace & Co. (NYSE: GRA) has introduced ProVance™ pre-packed columns, a portfolio of products for cost-effective purification of biologic drugs, specifically monoclonal antibodies (mAbs). Monoclonal antibodies are key therapeutic agents used to treat rheumatoid arthritis, cancer and other diseases. Currently in the U.S., mAbs constitute the single largest biologics product [...]

METTLER TOLEDO Thornton Introduces Portable Total Organic Carbon Analyzer for Pure Water Treatment Applications

METTLER TOLEDO Process Analytics Division has released the 450TOC Portable Total Organic Carbon Analyzer for use in pure water and ultrapure water treatment applications. High purity water is used across a variety of industries for many applications, ranging from a main ingredient in pharmaceutical and cosmetic products, washing and rinsing processes for microelectronics manufacturing, to [...]

Brooks Automation and BioCision Announce Equity Investment and Strategic Collaboration

CHELMSFORD, Mass. and LARKSPUR, Calif. -- Brooks Automation, Inc. (Nasdaq:BRKS), a global provider of automated sample storage systems for compound management and biorepositories, and BioCision, LLC, a leader in advanced technology to improve biomaterial sample handling and standardization, today announced they have established a relationship to support the development of technologies to improve temperature control [...]

Integrated DNA Technologies Advances Human Health and Clinical Research

CORALVILLE, IA – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, is extending its portfolio of NGS panels with the addition of the xGen® Inherited Disease and Pan-Cancer Panels. Adding these to the xGen AML Panel which was launched at the end of last year, IDT now offers a range of panels for [...]

HEPREGEN LAUNCHES FIRST HUMAN HEPATOPACTM ASSAY KIT TO EVALUATE HEPATOTOXICITY IN THE LABORATORY

Phoenix, Arizona – Today, at the Society of Toxicology’s 53rd Annual Meeting, Hepregen Corporation, a leader in the development of next generation HepatoPacTM and HepatoMuneTM cell-based in vitro assay products announced the commercial launch of the company’s first HepatoPacTM kit designed specifically for toxicology applications. The kit contains one or more standard 96-well tissue culture [...]

ProteinSimple Appoints Joe Keegan and Chris van Ingen to its Board of Directors

Santa Clara, CA - ProteinSimple announced today the appointments of two independent members of the company's Board of Directors, Mr. Chris van Ingen and Dr. Joe Keegan. "Chris and Joe are two of the most respected leaders in the life science tool industry," commented Tim Harkness, CEO of ProteinSimple. "They bring tremendous depth of experience [...]

Dr. Claire Pomeroy Elected as BD Director

Franklin Lakes, N.J. -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced the election of Dr. Claire Pomeroy to its Board of Directors. Dr. Pomeroy, 58, is an expert in infectious diseases and a long-time advocate for public health and patients, especially those with HIV/AIDS. She is currently President of [...]

GE completes acquisition of strategic assets from Thermo Fisher Scientific

CHALFONT ST. GILES, UK -- GE (NYSE:GE) announced today that it has completed the acquisition of Thermo Fisher's HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses. The acquisition allows GE to expand its offering of tools, technologies and services for the discovery and manufacture of innovative new medicines, vaccines and [...]

Introduction during Analytica 2014: The Center for Applied Nanotechnology shows newest product development CANdots® Series G – His Detect

Hamburg – The nano-experts from the Center for Applied Nanotechnology (CAN) GmbH expand their product portfolio by CANdots® Series G - His Detect, which is a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays. It is easy to handle, highly sensitive as well as time saving compared to standard methods available [...]

Thermo Fisher Scientific Completes Sale of Certain Biosciences Businesses to GE Healthcare

WALTHAM, Mass. - Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, today announced that it has completed the sale of its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company (NYSE: GE), for $1.065 billion. The businesses will become part of GE [...]

Access IBO on Knowledge Center